rs2276330

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP2BA1

This summary comes from the ClinGen Evidence Repository: The NM_004360.5(CDH1):c.1937-13T>C variant has an allele frequency of 0.16607 (16.6%, 4107/24730 alleles, 330 homozygotes) in the European (Finnish) subpopulation of the gnomAD v2.1.1 cohort (BA1; BP2). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA163616/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.095 ( 871 hom., cov: 31)
Exomes 𝑓: 0.12 ( 11676 hom. )

Consequence

CDH1
NM_004360.5 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:16

Conservation

PhyloP100: 0.184

Publications

30 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.1937-13T>C
intron
N/ANP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.1754-13T>C
intron
N/ANP_001304113.1P12830-2
CDH1
NM_001317185.2
c.389-13T>C
intron
N/ANP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.1937-13T>C
intron
N/AENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.1754-13T>C
intron
N/AENSP00000414946.2P12830-2
CDH1
ENST00000562836.5
TSL:1
n.2008-13T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0949
AC:
14433
AN:
152152
Hom.:
872
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0243
Gnomad AMI
AF:
0.0877
Gnomad AMR
AF:
0.0666
Gnomad ASJ
AF:
0.132
Gnomad EAS
AF:
0.0705
Gnomad SAS
AF:
0.0536
Gnomad FIN
AF:
0.159
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.137
Gnomad OTH
AF:
0.0920
GnomAD2 exomes
AF:
0.103
AC:
25875
AN:
250252
AF XY:
0.105
show subpopulations
Gnomad AFR exome
AF:
0.0211
Gnomad AMR exome
AF:
0.0476
Gnomad ASJ exome
AF:
0.121
Gnomad EAS exome
AF:
0.0795
Gnomad FIN exome
AF:
0.165
Gnomad NFE exome
AF:
0.136
Gnomad OTH exome
AF:
0.111
GnomAD4 exome
AF:
0.122
AC:
173911
AN:
1429786
Hom.:
11676
Cov.:
27
AF XY:
0.120
AC XY:
85559
AN XY:
713624
show subpopulations
African (AFR)
AF:
0.0225
AC:
739
AN:
32806
American (AMR)
AF:
0.0497
AC:
2222
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.127
AC:
3283
AN:
25918
East Asian (EAS)
AF:
0.0544
AC:
2150
AN:
39514
South Asian (SAS)
AF:
0.0543
AC:
4650
AN:
85578
European-Finnish (FIN)
AF:
0.169
AC:
8986
AN:
53066
Middle Eastern (MID)
AF:
0.0854
AC:
473
AN:
5540
European-Non Finnish (NFE)
AF:
0.133
AC:
144550
AN:
1083378
Other (OTH)
AF:
0.116
AC:
6858
AN:
59310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
7629
15259
22888
30518
38147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4922
9844
14766
19688
24610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0948
AC:
14431
AN:
152270
Hom.:
871
Cov.:
31
AF XY:
0.0932
AC XY:
6938
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0243
AC:
1009
AN:
41580
American (AMR)
AF:
0.0665
AC:
1017
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.132
AC:
457
AN:
3472
East Asian (EAS)
AF:
0.0709
AC:
367
AN:
5178
South Asian (SAS)
AF:
0.0536
AC:
259
AN:
4828
European-Finnish (FIN)
AF:
0.159
AC:
1684
AN:
10594
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.137
AC:
9332
AN:
68006
Other (OTH)
AF:
0.0915
AC:
193
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
659
1318
1977
2636
3295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.115
Hom.:
2225
Bravo
AF:
0.0869
Asia WGS
AF:
0.0500
AC:
174
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
Hereditary diffuse gastric adenocarcinoma (4)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
1
2
not provided (3)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Prostate cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
9.0
DANN
Benign
0.60
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
3.0
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276330; hg19: chr16-68857289; COSMIC: COSV55727021; COSMIC: COSV55727021; API